Back

Triglyceride glucose index and its combination with anthropometric obesity indicators are significant predictors of MAFLD among the Chinese population

31 August 2026 (08:15 - 08:45)
Organised by: Logo
Congress Presentation Part of: Adiposity and the heart (4) Obesity ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Mingwei Wang

Affiliated Hospital of Hangzhou Normal University, Hangzhou (China)

4 More presentations in this session

Presentation thumbnail
Comparison of cumulative central obesity indices for predicting midlife target organ damage: a 31-year Cohort Study
Doctor Q. Tai (Xi'an, CN)
Abstract
Presentation thumbnail
Differential effects of visceral and epicardial adiposity on cardiac remodeling and function in indigenous adults
Doctor M. Piche (Quebec, CA)
Abstract
Presentation thumbnail
Joint effects of low grip strength and abdominal obesity on major cardiovascular events: an analysis of the prospective urban rural epidemiology (PURE)-China cohort study
Mr C. Danzeng (Beijing, CN)
Abstract
Presentation thumbnail
Obesity is associated with elevated invasive filling pressures despite lower natriuretic peptides in patients with preserved ejection fraction
Doctor T. Murakami (Kawagoe, JP)
Abstract

Access the full session

Session thumbnail
Adiposity and the heart (4)

The Event

Event poster

ESC Congress 2026

31 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Comparison of the triglyceride-glucose index and triglyceride-HDL ratio as discriminators of metabolic syndrome in the elderly population
30 August 2025
thumbnail
Congress Presentation
Non-alcoholic fatty liver disease in patients with atrial fibrillation: a report from a global federated health network.
8 April 2024
thumbnail
Congress Presentation
impact of different cardiometabolic risk factors in MASLD: rethinking overweight/obesity criteria.
26 April 2024
thumbnail
Congress Presentation
Autoantibodies directed against apolipoprotein-a-1 as a potential contributor to non-alcoholic fatty liver disease
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources